PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced its participation in the prestigious 42nd Annual J.P. Morgan Healthcare Conference. The conference, set to take place in San Francisco, CA, will feature Harmony’s President and Chief Executive Officer, Jeffrey M. Dayno, M.D., as one of its key presenters.
Investors and industry stakeholders are eagerly awaiting Dr. Dayno’s presentation, scheduled for Wednesday, January 10, 2024, at 5:15 p.m. PT/8:15 p.m. ET. Given Harmony’s innovative work in the field of sleep medicine and neuroscience, his insights are expected to resonate with the conference’s audience, comprised of leading healthcare organizations, emerging companies, and investment communities.
The J.P. Morgan Healthcare Conference is a significant event in the healthcare sector, serving as a platform for companies to share their achievements, vision, and future strategies. Harmony’s participation in the conference underscores its position as a key player in the biopharmaceutical industry.
In a move to ensure that its investors and interested parties worldwide can be part of this momentous occasion, Harmony will host a live webcast of Dr. Dayno’s presentation. This webcast will be accessible on the investor page of Harmony’s website.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.